Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Centene Corp. | 27 | 0 | 3 | 0 | €66.13 | €82.57 | 24.861% |
| GSK plc ADR | 5 | 0 | 0 | 0 | €39.00 | €49.33 | 26.480% |
| Humana Inc. | 24 | 0 | 1 | 0 | €322.80 | €381.08 | 18.053% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €104.32 | €109.00 | 4.486% |
| Pfizer Inc. | 30 | 4 | 6 | 0 | €25.77 | €41.29 | 60.215% |
| Gilead Sciences Inc | 11 | 0 | 1 | 0 | €71.02 | €85.74 | 20.722% |
| Medtronic plc | 8 | 1 | 3 | 0 | €81.10 | €94.50 | 16.523% |
| Stryker Corp. | 31 | 0 | 2 | 0 | €323.90 | €340.93 | 5.257% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €14.15 | - | - |
| Veeva Systems A | 2 | 0 | 0 | 0 | €194.75 | - | - |
| HCA Holdings Inc. | 42 | 0 | 4 | 0 | €349.90 | €353.98 | 1.165% |
| AbbVie Inc. | 34 | 0 | 2 | 0 | €174.48 | €180.90 | 3.681% |
| Merck KGaA | 5 | 1 | 1 | 0 | €168.35 | €172.00 | 2.168% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €105.50 | €112.40 | 6.538% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €116.30 | €130.00 | 11.780% |
| Henry Schein Inc. | 15 | 1 | 3 | 0 | €62.06 | €76.08 | 22.590% |
| Hologic Inc. | 19 | 0 | 1 | 0 | €74.00 | €83.38 | 12.670% |
| Steris Corp. | 1 | 0 | 0 | 0 | €218.00 | - | - |
| Laboratory Corp. Of America (labcorp) | 15 | 0 | 0 | 0 | €197.00 | €239.41 | 21.527% |
| Idexx Laboratories Inc. | 12 | 0 | 0 | 0 | €426.10 | €554.23 | 30.070% |
| Eli Lilly Corp. | 68 | 0 | 10 | 0 | €815.00 | €831.01 | 1.964% |
| Sanofi S.A. ADR | 7 | 0 | 2 | 0 | €52.50 | €55.25 | 5.246% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €149.55 | €165.00 | 10.331% |
| Merck & Co. Inc. | 31 | 1 | 1 | 0 | €106.40 | €125.78 | 18.214% |
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €208.40 | €224.50 | 7.726% |